Keros Therapeutics Reports Recent First Quarter 2026 Financial Results

Go back to Keros Therapeutics Reports Recent First Quarter 2026 Financial Results
(NASDAQ: KROS) Delayed: 11.10 --0 (-0%)
Previous Close $11.10    52 Week High
Open $11.10    52 Week Low
Day High $11.10    P/E N/A 
Day Low $11.10    EPS
Volume 1,284